In silico prediction of the cosmetic whitening effects of naturally occurring lead compounds

Natural Product Communications

Volumn 7, Issue 10, 2012, Pages 1287-1294

  Fong, Pedro ^a   Tong, Henry H Y ^a  

^a MACAO POLYTECHNIC INSTITUTE   (Macao)

Author keywords

Ampelopsis japonica; Computer aided drug discovery; Ginkgo biloba; Lindera aggregata; Tyrosinase

Indexed keywords

ARBUTIN; COSMETIC; ENZYME INHIBITOR; GALLOCATECHIN GALLATE; GINKGOLIDE C; GINKGOLIDE J; KOJIC ACID; LINDERAGALACTONE C; MONOPHENOL MONOOXYGENASE; N METHYLLAUROTETANINE; NEOLINDERAALACTONE; NORBOLDINE; ORGANOLEAD COMPOUND; PALLIDINE; RETICULINE; TYROSINASE INHIBITOR; UNCLASSIFIED DRUG;

AMPELOPSIS; AMPELOPSIS JAPONICA; ARTICLE; BINDING AFFINITY; CHEMICAL COMPOSITION; COMPUTER ANALYSIS; COMPUTER PROGRAM; CONTROLLED STUDY; CORROSION; DRUG EFFECT; DRUG FORMULATION; ENZYME BINDING; GINKGO BILOBA; LINDERA; LINDERA AGGREGATA; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NONHUMAN; PREDICTION; SCORING SYSTEM; SIMULATION; SKIN IRRITATION; SKIN IRRITATION CORROSION RULES ESTIMATION TOOL; SKIN PERMEABILITY; WHITENING EFFECT;

EID: 84869855552     PISSN: 1934578X     EISSN: 15559475     Source Type: Journal    
DOI: 10.1177/1934578x1200701010     Document Type: Article

References (68)

1. Briganti S, Camera E, Picardo M. (2003) Chemical and instrumental approaches to treat hyperpigmentation. Pigment Cell Research, 16, 101-110. (Pubitemid 36596955)
2. Lim JT. (1999) Treatment of melasma using kojic acid in a gel containing hydroquinone and glycolic acid. Dermatologic Surgery, 25, 282-284.
3. Funayama M, Arakawa H, Yamamoto R, Nishino T, Shin T, Murao S. (1995) Effects of α- and β-arbutin on activity of tyrosinases from mushroom and mouse melanoma. Bioscience, Biotechnology, and Biochemistry, 59, 143-144.
4. Lu YH, Chen J, Wei DZ, Wang ZT, Tao XY. (2009) Tyrosinase inhibitory effect and inhibitory mechanism of tiliroside from raspberry. Journal of Enzyme Inhibition and Medicinal Chemistry, 24, 1154-1160.
5. Wang KH, Lin RD, Hsu FL, Huang YH, Chang HC, Huang CY, Lee MH. (2006) Cosmetic applications of selected traditional Chinese herbal medicines. Journal of Ethnopharmacology, 106, 353-359.
6. Newman DJ, Cragg GM. (2007) Natural products as sources of new drugs over the last 25 years. Journal of Natural Products, 70, 461-477. (Pubitemid 46595760)
7. Ye Y, Chou GX, Mu DD, Wang H, Chu JH, Leung AK, Fong WF, Yu ZL. (2010) Screening of Chinese herbal medicines for antityrosinase activity in a cell free system and B16 cells. Journal of Ethnopharmacology, 129, 387-390.
8. Arung ET, Shimizu K, Kondo R. (2011) Artocarpus plants as a potential source of skin whitening agents. Natural Product Communications, 6, 1397-1402.
9. Jain AN. (2007) Surflex-Dock 2.1: robust performance from ligand energetic modeling, ring flexibility, and knowledge-based search. Journal of Computer-Aided Molecular Design, 21, 281-306.
10. Chen YC. (2011) TCM Database@Taiwan: The world's largest traditional Chinese medicine database for drug screening in silico. PLoS ONE, 6, e15939.
11. Chang TS. (2009) An updated review of tyrosinase inhibitors. International Journal of Molecular Sciences, 10, 2440-2475.
12. Asanuma M, Miyazaki I, Ogawa N. (2003) Dopamine- or L-DOPA-induced neurotoxicity: the role of dopamine quinone formation and tyrosinase in a model of Parkinson's disease. Neurotoxicity Research, 5, 165-176.
13. Draelos ZD. (2007) Skin lightening preparations and the hydroquinone controversy. Dermatologic Therapy, 20, 308-313.
14. Matoba Y, Kumagai T, Yamamoto A, Yoshitsu H, Sugiyama M. (2006) Crystallographic evidence that the dinuclear copper center of tyrosinase is flexible during catalysis. Journal of Biological Chemistry, 281, 8981-8990. (Pubitemid 43848005)
15. Jeong SH, Ryu YB, Curtis-Long MJ, Ryu HW, Baek YS, Kang JE, Lee WS, Park KH. (2009) Tyrosinase inhibitory polyphenols from roots of Morus lhou. Journal of Agricultural and Food Chemistry, 57, 1195-1203.
16. Pieper U, Webb BM, Barkan DT, Schneidman-Duhovny D, Schlessinger A, Braberg H, Yang Z, Meng EC, Pettersen EF, Huang CC, Datta RS, Sampathkumar P, Madhusudhan MS, Sjolander K, Ferrin TE, Burley SK, Sali A. (2011) ModBase, a database of annotated comparative protein structure models, and associated resources. Nucleic Acids Research, 39, D465-474.
17. US EPA. Overview: Office of Pollution Prevention & Toxics Programs (2007).
18. Enoch SJ, Madden JC, Cronin MT. (2008) Identification of mechanisms of toxic action for skin sensitisation using a SMARTS pattern based approach. SAR and QSAR in Environmental Research, 19, 555-578.
19. Walker JD, Gerner I, Hulzebos E, Schlegel K. (2005) The skin irritation corrosion rules estimation tool (SICRET). QSAR & Combinatorial Science, 24, 378-384. (Pubitemid 40637939)
20. Ye Y, Chou GX, Mu DD, Wang H, Chu JH, Leung AK, Fong WF, Yu ZL. (2010) Screening of Chinese herbal medicines for antityrosinase activity in a cell free system and B16 cells. Journal of Ethnopharmacology, 129, 387-390.
21. Espin JC, Wichers HJ. (1999) Slow-binding inhibition of mushroom (Agaricus bisporus) tyrosinase isoforms by tropolone. Journal of Agricultural and Food Chemistry, 47, 2638-2644. (Pubitemid 29396332)
22. Kim YM, Yun J, Lee CK, Lee H, Min KR, Kim Y. (2002) Oxyresveratrol and hydroxystilbene compounds. Inhibitory effect on tyrosinase and mechanism of action. Journal of Biological Chemistry, 277, 16340-16344. (Pubitemid 34967923)
23. Bookout RL, Jr., McDaniel CR, Quinn DW, McDougal JN. (1996) Multilayered dermal subcompartments for modeling chemical absorption. SAR and QSAR in Environmental Research, 5, 133-150.
24. Takebayashi J, Ishii R, Chen J, Matsumoto T, Ishimi Y, Tai A. (2010) Reassessment of antioxidant activity of arbutin: multifaceted evaluation using five antioxidant assay systems. Free Radical Research, 44, 473-478.
25. Kohen R. (1999) Skin antioxidants: their role in aging and in oxidative stress - new approaches for their evaluation. Biomedicine and Pharmacotherapy, 53, 181-192.
26. Leelapronpisid P, Leesawat P, Natakarnkitkul S, Rattanapanadda P. (2010) Application of chitosan for preparation of arbutin nanoparticles as skin whitening. Journal of Metals, Materials and Minerals, 20, 101-105.
27. Maclennan KM, Darlington CL, Smith PF. (2002) The CNS effects of Ginkgo biloba extracts and ginkgolide B. Progress in Neurobiology, 67, 235-257. (Pubitemid 34880132)
28. Lu S, Guo X, Zhao P. (2011) Effect of Ginkgo biloba extract 50 on immunity and antioxidant enzyme activities in ischemia reperfusion rats. Molecules, 16, 9194-9206.
29. Brown LA, Riby LM, Reay JL. (2010) Supplementing cognitive aging: a selective review of the effects of Ginkgo biloba and a number of everyday nutritional substances. Experimental Aging Research, 36, 105-122.
30. Mahady GB. (2001) Ginkgo biloba: a review of quality, safety, and efficacy. Nutrition in Clinical Care, 4, 140-147.
31. Lei HP, Ji W, Lin J, Chen H, Tan ZR, Hu DL, Liu LJ, Zhou HH. (2009) Effects of Ginkgo biloba extract on the pharmacokinetics of bupropion in healthy volunteers. British Journal of Clinical Pharmacology, 68, 201-206.
32. Cho HJ, Shon YH, Nam KS. (2007) Ginkgolide C inhibits platelet aggregation in cAMP- and cGMP-dependent manner by activating MMP-9. Biological and Pharmaceutical Bulletin, 30, 2340-2344.
33. He J, Petrovic AG, Dzyuba SV, Berova N, Nakanishi K, Polavarapu PL. (2008) Spectroscopic investigation of Ginkgo biloba terpene trilactones and their interaction with amyloid peptide Aβ (25-35). Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy, 69, 1213-1222. (Pubitemid 351380517)
34. Gan LS, Yao W, Mo JX, Zhou CX. (2009) Alkaloids from Lindera aggregata. Natural Product Communications, 4, 43-46.
35. Wang F, Gao Y, Zhang L, Bai B, Hu YN, Dong ZJ, Zhai QW, Zhu HJ, Liu JK. (2010) A pair of windmill-shaped enantiomers from Lindera aggregata with activity toward improvement of insulin sensitivity. Organic Letters, 12, 3196-3199.
36. Wang C, Dai Y, Yang J, Chou G, Wang Z. (2007) Treatment with total alkaloids from Radix Linderae reduces inflammation and joint destruction in type II collagen-induced model for rheumatoid arthritis. Journal of Ethnopharmacology, 111, 322-328. (Pubitemid 46528085)
37. Wang R, Tang S, Zhai H, Duan H. (2011) Studies on anti-tumor metastatic constituents from Lindera glauca. China Journal of Chinese Materia Medica, 36, 1032-1036.
38. Boustie J, Stigliani JL, Montanha J, Amoros M, Payard M, Girre L. (1998) Antipoliovirus structure-activity relationships of some aporphine alkaloids. Journal of Natural Products, 61, 480-484. (Pubitemid 28217509)
39. N)2- reactive chemicals. Chemical Research in Toxicology, 24, 2018-2027.
40. Zhao Q, Zhao Y, Wang K. (2006) Antinociceptive and free radical scavenging activities of alkaloids isolated from Lindera angustifolia. Journal of Ethnopharmacology, 106, 408-413.
41. Fuller BB, Drake MA, Spaulding DT, Chaudhry F. (2000) Downregulation of tyrosinase activity in human melanocyte cell cultures by yohimbine. Journal of Investigative Dermatology, 114, 268-276. (Pubitemid 30417760)
42. Bai M, Jia Y, Yang K, Sun S, Miao M. (2011) Clinical topical and pharmacological action research progress of Radix ampelopsis. China Modern Medicine, 18, 13-14.
43. Tong HY, Ho KP, Chow HL. (2005) Comparative studies on tyrosinase inhibitory activities of aqueous and ethanolic extracts of cosmetic whitening traditional Chinese medicines. Chinese Pharmaceutical Journal, 40, 342-343. (Pubitemid 40686438)
44. No JK, Soung DY, Kim YJ, Shim KH, Jun YS, Rhee SH, Yokozawa T, Chung HY. (1999) Inhibition of tyrosinase by green tea components. Life Sciences, 65, PL241-246.
45. Gomez-Guzman M, Jimenez R, Sanchez M, Zarzuelo MJ, Galindo P, Quintela AM, Lopez-Sepulveda R, Romero M, Tamargo J, Vargas F, Perez-Vizcaino F, Duarte J. (2011) Epicatechin lowers blood pressure, restores endothelial function, and decreases oxidative stress and endothelin-1 and NADPH oxidase activity in DOCA-salt hypertension. Free Radical Biology and Medicine, 52, 70-79.
46. Hsu YW, Tsai CF, Chen WK, Huang CF, Yen CC. (2011) A subacute toxicity evaluation of green tea (Camellia sinensis) extract in mice. Food and Chemical Toxicology, 49, 2624-2630.
47. Rodriguez M, Du GJ, Wang CZ, Yuan CS. (2010) Letter to the editor: Panaxadiol's anticancer activity is enhanced by epicatechin. American Journal of Chinese Medicine, 38, 1233-1235.
48. Betts JW, Kelly SM, Haswell SJ. (2011) Antibacterial effects of theaflavin and synergy with epicatechin against clinical isolates of Acinetobacter baumannii and Stenotrophomonas maltophilia. International Journal of Antimicrobial Agents, 38, 421-425.
49. Chow HH, Hakim IA, Vining DR, Crowell JA, Cordova CA, Chew WM, Xu MJ, Hsu CH, Ranger-Moore J, Alberts DS. (2006) Effects of repeated green tea catechin administration on human cytochrome P450 activity. Cancer Epidemiology, Biomarkers and Prevention, 15, 2473-2476. (Pubitemid 46048307)
50. Bianchi A, Marchetti N, Scalia S. (2011) Photodegradation of (-)-epigallocatechin-3-gallate in topical cream formulations and its photostabilization. Journal of Pharmaceutical and Biomedical Analysis, 56, 692-697.
51. Wisuitiprot W, Somsiri A, Ingkaninan K, Waranuch N. (2011) In vitro human skin permeation and cutaneous metabolism of catechins from green tea extract and green tea extract-loaded chitosan microparticles. International Journal of Cosmetic Science, 33, 572-579.
52. Fiser A, Sali A. (2003) Modeller: generation and refinement of homology-based protein structure models. Methods in Enzymology, 374, 461-491. (Pubitemid 37531821)
53. James JPS. MOPAC2009. Colorado Springs, CO, USA: Stewart Computational Chemistry, 2008.
54. Stewart JJ. (2007) Optimization of parameters for semiempirical methods V: modification of NDDO approximations and application to 70 elements. Journal of Molecular Modeling, 13, 1173-1213.
55. Rho HS, Lee CS, Ahn S, Hong YD, Shin SS, Park HY, Park SN. (2011) Studies on tyrosinase inhibitory and antioxidant activities of benzoic acid derivatives containing kojic acid moiety. Bulletin of the Korean Chemical Society, 32, 4411-4414.
56. Baek HS, Hong YD, Lee CS, Rho HS, Shin SS, Park YH, Joo YH. (2012) Adamantyl N-benzylbenzamide: new series of depigmentation agents with tyrosinase inhibitory activity. Bioorganic and Medicinal Chemistry Letters, 22, 2110-2113.
57. Thanigaimalai P, Lee KC, Sharma VK, Joo C, Cho WJ, Roh E, Kim Y, Jung SH. (2011) Structural requirement of phenylthiourea analogs for their inhibitory activity of melanogenesis and tyrosinase. Bioorganic and Medicinal Chemistry Letters, 21, 6824-6828.
58. Lexa KW, Carlson HA. (2012) Protein flexibility in docking and surface mapping. Quarterly Reviews of Biophysics, Epub, 1-43.
59. Wallace AC, Laskowski RA, Thornton JM. (1995) LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions. Protein Engineering, 8, 127-134.
60. The PyMOL Molecular Graphics System, Version 1.5.0.4 Schrödinger, LLC.
61. Monteiro-Riviere NA, Bristol DG, Manning TO, Rogers RA, Riviere JE. (1990) Interspecies and interregional analysis of the comparative histologic thickness and laser Doppler blood flow measurements at five cutaneous sites in nine species. Journal of Investigative Dermatology, 95, 582-586.
62. Poet TS, Corley RA, Thrall KD, Edwards JA, Tanojo H, Weitz KK, Hui X, Maibach HI, Wester RC. (2000) Assessment of the percutaneous absorption of trichloroethylene in rats and humans using MS/MS real-time breath analysis and physiologically based pharmacokinetic modeling. Toxicological Sciences, 56, 61-72. (Pubitemid 30441465)
63. Poet TS, McDougal JN. (2002) Skin absorption and human risk assessment. Chemico-Biological Interactions, 140, 19-34. (Pubitemid 34606849)
64. Mitragotri S, Anissimov YG, Bunge AL, Frasch HF, Guy RH, Hadgraft J, Kasting GB, Lane ME, Roberts MS. (2011) Mathematical models of skin permeability: an overview. International Journal of Pharmaceutics, 1, 115-129.
65. Potts RO, Mak VH, Guy RH, Francoeur ML. (1991) Strategies to enhance permeability via stratum corneum lipid pathways. Advances in Lipid Research, 24, 173-210.
66. Roberts DW, Aptula AO, Patlewicz G. (2006) Mechanistic applicability domains for non-animal based prediction of toxicological endpoints. QSAR analysis of the Schiff base applicability domain for skin sensitization. Chemical Research in Toxicology, 19, 1228-1233. (Pubitemid 44454040)
67. Roberts DW, Patlewicz G, Dimitrov SD, Low LK, Aptula AO, Kern PS, Dimitrova GD, Comber MI, Phillips RD, Niemela J, Madsen C, Wedebye EB, Bailey PT, Mekenyan OG. (2007) TIMES-SS - a mechanistic evaluation of an external validation study using reaction chemistry principles. Chemical Research in Toxicology, 20, 1321-1330. (Pubitemid 47548300)
68. Hulzebos E, Walker JD, Gerner I, Schlegel K. (2005) Use of structural alerts to develop rules for identifying chemical substances with skin irritation or skin corrosion potential QSAR & Combinatorial Science, 24, 332-342. (Pubitemid 40637935)